Adaptive Biotechnologies Expands Executive Leadership Team to Support Development and Commercialization of Clinical Products, including immunoSEQ Dx

NEXT STORY
Global Respiratory Care Devices Market Is Expected to Reach USD 41.20 Billion by 2027 : Fior Markets
PREV STORY
KESSLER TOPAZ MELTZER & CHECK, LLP – IMPORTANT DEADLINE REMINDER FOR INOVIO PHARMACEUTICALS, INC. INVESTORS
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Galena Biopharma Presents Positive Final GALE-301 (E39) Phase 1/2a Clinical Trial Data

SAN RAMON, Calif., March 17, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a ...

author_avatar
NASDAQ Market News

Vifor Pharma and Akebia Announce Exclusive License Agreement to Provide Vadadustat to Fresenius Medical Care in the U.S. Upon FDA Approval

                                                   --   Vifor Pharma Commits to Exclusive Distribution of Vadadustat to Fresenius Medical Care North America ...

author_avatar
NASDAQ Market News

VASCEPA® (Icosapent Ethyl) Found to Significantly Reduce Ischemic Events in Patients with Prior Coronary Artery Bypass Grafting (CABG) Procedures in Post Hoc Subgroup Analyses of Landmark REDUCE-IT® Study Presented at American Heart Association’s Virtual Scientific Sessions 2020

author_avatar
NASDAQ Market News